SWEDISH ORPHAN/S (SWTUY) News Today → Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad) Free SWTUY Stock Alerts $24.38 -0.29 (-1.18%) (As of 04/9/2019) Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSwedish Orphan Biovitrum AB: Aspaveli® (pegcetacoplan) approved in Europe for use among treatment naïve adult patients with PNHfinanznachrichten.de - May 8 at 5:36 AMDenmark's new monarchs visit Sweden on first official trip abroadfoxnews.com - May 6 at 4:46 PMDeciphera to sell for $2.4B, adding to upswing in biopharma M&Afinance.yahoo.com - April 29 at 5:55 PMMore premature babies born following Swedish parental leave policymsn.com - April 8 at 5:49 PMSwedish Scientists Confirm: Knitting Is Your Brain's Best Friendmsn.com - April 3 at 5:17 PMBulgarian cruise ship crashes into wall on Danube in Austria, injuring 11msn.com - March 30 at 3:51 PMCrown Princess Victoria of Sweden, Swedish Minister Johan Forssell to visit Bangladesh March 18-21msn.com - March 17 at 1:32 PMSweden set to become NATO's 32nd member as PM visits Washingtonmsn.com - March 7 at 8:55 AMDeath and grief in Swedish children's booksmsn.com - February 21 at 5:19 PMUPDATE 2-Sweden's Vattenfall to move ahead with nuclear plansmsn.com - February 19 at 3:40 PMOrexo and Sobi agree to advance feasibility study with AmorphOXfinanznachrichten.de - February 12 at 9:00 AMRevolutionizing Historical Research: Swedish Lion AI Unveiledmsn.com - February 10 at 3:07 PMHere's what Wall Street expects from Swedish Orphan Biovitrum AB's earnings reportmarkets.businessinsider.com - February 8 at 2:55 AMClues from the ice age can help restore Swedish streamsmsn.com - February 6 at 2:10 PMA Day Trip To Uppsala, Sweden’s City Of Historyforbes.com - January 19 at 10:07 AMSweden's call for population to prepare for war sparks panic and criticismmsn.com - January 18 at 10:46 PMScientists Unearth Centuries-Old Secrets From Swedish Shipwreckmsn.com - January 11 at 8:42 AMSwedish Shipwreck Gives Inside Look at Life for Baltic Sailors Centuries Agomsn.com - January 11 at 12:37 AMSwedish £6,000 dine and dash investigation reopenedmsn.com - January 10 at 1:38 PM'Prepare for war!' Swedish government tells citizens to prepare for the worstmsn.com - January 10 at 1:38 PMSwedish snow chaos leaves 1,000 vehicles trappedmsn.com - January 4 at 12:34 PMUkrainian orphan Natalia Grace’s DNA test confirms her real age after she’s accused of ‘masquerading’ as a child, trying to kill parentsmsn.com - January 4 at 7:34 AMSweden’s Coop confirms cyberattack on Värmland storesmsn.com - January 3 at 3:25 PMRadiographic study exposes ancient oral health of Swedish Vikingsmsn.com - January 2 at 11:16 PM'Santa Claus' Triggers Bomb Scare at Swedish Airportmsn.com - December 30 at 9:22 AMCytokine Release Syndrome Market Research Report 2022 Featuring Genentech, Novartis, Incyte, CytoSorbents, Jazz Pharma, Swedish Orphan Biovitrumbenzinga.com - June 9 at 7:50 AMSwedish Orphan Biovitrum AB: Sobi: FDA grants efanesoctocog alfa Breakthrough Therapy designation for haemophilia Afinanznachrichten.de - June 2 at 11:16 PMSanofi: FDA Grants Efanesoctocog Alfa Breakthrough Therapy Designation For Hemophilia Amarkets.businessinsider.com - June 1 at 2:19 AMSobi: FDA grants efanesoctocog alfa Breakthrough Therapy designation for haemophilia Ayahoo.com - June 1 at 2:19 AMSelecta Biosciences Reports First Quarter 2022 Financial Results and Provides Business Updatetmcnet.com - May 5 at 8:56 AMSpago Nanomedical Interim Report January-March 2022yahoo.com - April 27 at 8:10 AMAnakinra Market Analysis, Trends, Growth, Size, Share and Forecast 2023 to 2025marketwatch.com - April 16 at 11:21 PMSwedish Orphan Biovitrum AB: Sobi to cease ReFacto manufacturing in the first quarter of 2024finanznachrichten.de - March 24 at 9:00 PMSwedish Orphan Biovitrum(SWTUY)fool.com - March 12 at 11:36 PMSanofi, Sobi's hemophilia A therapy provides bleeding protection, meets main goal of studyseekingalpha.com - March 9 at 9:28 AMSanofi Says New Hemophilia Drug Met Primary, Secondary Endpoints in Studymorningstar.com - March 9 at 4:13 AMSanofi: Efanesoctocog Alfa Meets Primary, Key Secondary Endpoints In Phase 3 Study In Hemophilia Anasdaq.com - March 9 at 4:13 AMApellis (APLS) Q4 Loss Widens, Revenues Surpass Estimatesmsn.com - March 1 at 11:18 AMAnakinra Market Analysis, Size, Trends, Insights and Forecast to 2027marketwatch.com - February 26 at 7:10 PMEryDel Appoints Thomas Sabia as Chief Commercial Officerfinance.yahoo.com - February 22 at 4:21 PMSwedish Orphan Biovitrum AB: Sobi to present new data at EAHAD 2022finanznachrichten.de - February 2 at 2:38 PMSwedish Orphan Biovitrum AB: Aspaveli (pegcetacoplan) approved in EU as orphan drug for treatment of PNHfinanznachrichten.de - December 16 at 8:22 PMSwedish Orphan Biovitrum AB: Kineret (anakinra) receives positive opinion from the CHMP for treatment of patients with COVID-19 pneumoniafinanznachrichten.de - December 16 at 3:22 PMThe European Union's medicines agency on Thursday recommended two new treatments against Covid-19 for use in the bloc.msn.com - December 16 at 10:22 AMSwedish Orphan Biovitrum's Kineret Gets Nod for Use in Covid-19 Patientsmarketwatch.com - December 16 at 10:22 AMThe Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPObenzinga.com - December 15 at 8:47 AMApellis and Sobi Report Empaveli™ (pegcetacoplan) Demonstrated Sustained Normalization of Clinical Measures in a Broad PNH Patient Populationyahoo.com - December 13 at 1:12 PMApellis and Sobi Report Empaveli(TM) (pegcetacoplan) Demonstrated Sustained Normalization of Clinical Measures in a Broad PNH Patient Populationstockhouse.com - December 13 at 1:12 PMSelecta Biosciences and Sobi Announce Completion of Enrollment in DISSOLVE Phase 3 Study Evaluating SEL-212 for Chronic Refractory Goutfinance.yahoo.com - December 1 at 9:11 AMApellis and Sobi Receive Positive CHMP Opinion for Aspaveli® (pegcetacoplan) for the Treatment ...apnews.com - October 16 at 9:24 AM Get SWEDISH ORPHAN/S News Delivered to You Automatically Sign up to receive the latest news and ratings for SWTUY and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Your Bank Account Before It’s Too Late (Ad)For months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction … Stop right now and do these 3 things to protect yourself SWTUY Media Mentions By Week SWTUY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SWTUY News Sentiment▼0.000.36▲Average Medical News Sentiment SWTUY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SWTUY Articles This Week▼21▲SWTUY Articles Average Week Get SWEDISH ORPHAN/S News Delivered to You Automatically Sign up to receive the latest news and ratings for SWTUY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Aurora Cannabis News Today Amplifon News Today Sino Biopharmaceutical News Today Aspen Pharmacare News Today Hikma Pharmaceuticals News Today Zealand Pharma A/S News Today Orion Oyj News Today Sonic Healthcare News Today GN Store Nord A/S News Today Recordati Industria Chimica e Farmaceutica News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:SWTUY) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressObama’s Forever Term [exposed]Porter & CompanyThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable ProsperityThe #1 Crypto for AIWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SWEDISH ORPHAN/S Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
